Bio
Mr. Singer has led Maverick’s private investments since joining the firm in 2004. Prior to Maverick, he was the founding CEO of three companies: Affymetrix (NASDAQ: AFFX); Corcept Therapeutics (NASDAQ: CORT); and Genesoft Pharmaceuticals (NASDAQ: OSCI).
During his career, he has served on the boards of 28 private companies including seven that became public companies during his service. Among the boards Mr. Singer has served on are: Affymetrix, Corcept Therapeutics, CoreValve, Coupang, OneMedical, Pacific BioSciences and Seer.
He received a B.A. from Yale University and an M.B.A. from Stanford University. He is Vice Chair of College Track and is a Lecturer at the Stanford Graduate School of Business. In 2023 and 2024, Mr. Singer was included in Forbes’ Midas List of the world’s best venture capital investors. He lives in San Francisco with his wife Diana Kapp.
Academic Degrees
- MBA, Stanford Graduate School of Business, 1988
- BA in History, Yale University, 1984